NuVasive Inc (NUVA)

NASDAQ
45.78
+0.78(+1.73%)
  • Volume:
    286,591
  • Day's Range:
    44.35 - 45.78
  • 52 wk Range:
    35.17 - 60.47

NUVA Overview

Prev. Close
45
Day's Range
44.35-45.78
Revenue
896.49M
Open
45.3
52 wk Range
35.17-60.47
EPS
-0.393
Volume
286,591
Market Cap
2.39B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
900,590
P/E Ratio
-116.18
Beta
1.03
1-Year Change
-9.27%
Shares Outstanding
52,133,961
Next Earnings Date
Feb 22, 2023
What is your sentiment on NuVasive?
or
Vote to see community's results!

NuVasive Inc Analysis

NuVasive Inc Company Profile

NuVasive Inc Company Profile

Nuvasive, Inc. is a medical technology company, which is focused on developing, manufacturing, selling and providing procedural solutions for spine surgery, with a guiding purpose to transform surgery, advance care and change lives. The Company offers a comprehensive portfolio of procedurally integrated spine surgery solutions, including surgical access instruments, spinal implants, fixation systems, biologics and enabling technologies, as well as systems and services for intraoperative neuromonitoring. In addition, it develops and sells magnetically adjustable implant systems for spine and specialized orthopedic procedures. In addition, it also designs and sells expandable growing rod implant systems for the treatment of early-onset scoliosis, which can be non-invasively lengthened implantation with precise, incremental adjustments via an external remote controller using magnetic technology called MAGnetic External Control (MAGEC).

Read More

Analyst Price Target

Average47.33 (+3.39% Upside)
High63.00
Low38.00
Price45.78
No. of Analysts15
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyStrong BuyStrong BuyStrong BuySell
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong BuyStrong Sell
SummaryStrong BuyStrong BuyStrong BuyStrong BuyStrong Sell
  • Yes
    0
    • NUVA looks good range $44.43 to $41 can test $52 support at $39. short term
      0
      • Very good
        0
      • Hm
        0